MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/eci.12053

Медицинская библиотека · European journal of clinical investigation · 2013

The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways.

Peng Yu, Yang Huixiang, Zhu Tingting, Zhao Menghua, Deng Yuexia, Liu Bin, Shen Hong, Hu Gaoyun, Wang Zhaohe, Tao Lijian

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Fluorofenidone (AKF-PD) is a novel pyridone agent. The purpose of this study is to investigate the inhibitory effects of AKF-PD on dimethylnitrosamine (DMN)-induced liver fibrosis in rats and the involved molecular mechanism related to hepatic stellate cells (HSCs).

MATERIALS AND

METHODS

Wistar rats were randomly divided into normal control, DMN, DMN/AKF-PD treatment and DMN/pirfenidone (PFD) treatment groups. AKF-PD and PFD treatments were, respectively, performed for two activated HSCs lines, rat CFSC-2G and human LX2. The cell proliferation was analysed by MTT. The expression of collagen I was determined by immunohistochemical staining and real-time RT-PCR. The expression of α-smooth muscle actin (α-SMA), tissue inhibitor of metalloproteinases-1 (TIMP-1), extracellular signal regulated kinase (ERK1/2), p38 MAPK (p38), and c-Jun N-terminal kinase/stress-activated protein kinase (JNK) were also detected by real-time RT-PCR and/or Western blot.

RESULTS

AKF-PD significantly reduced PDGF-BB-induced proliferation and activation of HSCs, as determined by reducing protein expression of α-SMA and TIMP-1. AKF-PD treatment attenuated PDGF-BB-induced upregulation of phosphorylation of ERK1/2, p38 and JNK. In fibrotic rat liver, AKF-PD reduced the degree of liver injury and hepatic fibrosis, which was associated with reduced the expression of collagen I, α-SMA, TIMP-1 at both mRNA and protein levels.

CONCLUSION

AKF-PD treatment inhibits the progression of hepatic fibrosis by suppressing HSCs proliferation and activation via MAPK signalling pathway.

Для цитирования: Peng Yu, Yang Huixiang, Zhu Tingting, Zhao Menghua, Deng Yuexia, Liu Bin, Shen Hong, Hu Gaoyun, Wang Zhaohe, Tao Lijian. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways.. European journal of clinical investigation. 2013. DOI: 10.1111/eci.12053.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.